List of works - Kirsten Kübler

A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer

scientific article

Accumulation of ALDH1-positive cells after neoadjuvant chemotherapy predicts treatment resistance and prognosticates poor outcome in ovarian cancer.

scientific article

Foxp3(+) cell infiltration and granzyme B(+)/Foxp3(+) cell ratio are associated with outcome in neoadjuvant chemotherapy-treated ovarian carcinoma

scientific article published on 20 January 2010

Genetic alterations of HLA-class II in ovarian cancer

scientific article published on 01 September 2008

HLA-class II haplotype associations with ovarian cancer.

scientific article

High-risk pregnancy management in women with hypopituitarism.

scientific article published on February 2009

Immunogenic cell death of human ovarian cancer cells induced by cytosolic poly(I:C) leads to myeloid cell maturation and activates NK cells.

scientific article

In vivo intratumor angiogenic treatment effects during taxane-based neoadjuvant chemotherapy of ovarian cancer.

scientific article

Individual management of cervical cancer in pregnancy.

scientific article

N-terminal pro-B-type natriuretic peptide in the circulation of fetuses with cardiac malformations.

scientific article

Prognostic significance of tumor-associated macrophages in endometrial adenocarcinoma

scientific article published on 27 August 2014

RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissues

scientific article published on 01 June 2019

Reference values for N-terminal pro-B-type natriuretic peptide in fetal circulation between 20 and 34 weeks of gestation.

scientific article published on 5 December 2009

Sequence-specific activation of the DNA sensor cGAS by Y-form DNA structures as found in primary HIV-1 cDNA

scientific article

Sorafenib in combination with carboplatin and paclitaxel as neoadjuvant chemotherapy in patients with advanced ovarian cancer.

scientific article published on 5 March 2010

Tumoral PD-L1 expression defines a subgroup of poor-prognosis vulvar carcinomas with non-viral etiology

scientific article published on 6 October 2017

Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in Hürthle Cell Carcinoma

scientific article published on 01 August 2018

List of works by Kirsten Kübler

A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer

Accumulation of ALDH1-positive cells after neoadjuvant chemotherapy predicts treatment resistance and prognosticates poor outcome in ovarian cancer.

Foxp3(+) cell infiltration and granzyme B(+)/Foxp3(+) cell ratio are associated with outcome in neoadjuvant chemotherapy-treated ovarian carcinoma

Genetic alterations of HLA-class II in ovarian cancer

HLA-class II haplotype associations with ovarian cancer.

High-risk pregnancy management in women with hypopituitarism.

Immunogenic cell death of human ovarian cancer cells induced by cytosolic poly(I:C) leads to myeloid cell maturation and activates NK cells.

In vivo intratumor angiogenic treatment effects during taxane-based neoadjuvant chemotherapy of ovarian cancer.

Individual management of cervical cancer in pregnancy.

N-terminal pro-B-type natriuretic peptide in the circulation of fetuses with cardiac malformations.

Prognostic significance of tumor-associated macrophages in endometrial adenocarcinoma

RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissues

Reference values for N-terminal pro-B-type natriuretic peptide in fetal circulation between 20 and 34 weeks of gestation.

Sequence-specific activation of the DNA sensor cGAS by Y-form DNA structures as found in primary HIV-1 cDNA

Sorafenib in combination with carboplatin and paclitaxel as neoadjuvant chemotherapy in patients with advanced ovarian cancer.

Tumoral PD-L1 expression defines a subgroup of poor-prognosis vulvar carcinomas with non-viral etiology

Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in Hürthle Cell Carcinoma